The MSK-MET cohort analysis, which involved prospective clinical sequencing of 25,000 patients, also revealed an association between adrenal gland metastasis and mutations in both SMARCA4 and TP53, as well as a correlation of TP53 mutations with CNS metastasis in NSCLC patients [220]. Here, TP53 is linked to non-small cell lung carcinoma.